多发性骨髓瘤全身MRI半定量评分系统的开发
本研究基于两个回顾组和一个前瞻组新诊断多发性骨髓瘤患者,开发并验证了整合骨髓背景模式、局灶性骨病灶数目及髓外或椎旁病灶三项特征的全身MRI半定量评分系统(总分0-9分),观察者间一致性为κ 0.69-0.80,总分随ISS分期(P=.009)和R-ISS分期(P=.005)增高而增加。
要点
- 评分系统整合骨髓背景模式、局灶性骨病灶数目、髓外或椎旁病灶三项特征,总分0-9分。
- 三项特征的观察者间一致性为κ 0.69-0.80,属高度一致。
- 全身MRI总分随ISS分期和R-ISS分期增高而增加(P分别为.009和.005)。
核心结论
- 所开发的全身MRI半定量评分系统观察者间一致性达高度一致,且与ISS和R-ISS分期对应良好。
研究设计与样本
- 研究包含两个回顾组(组1:2015年7月至2021年9月;组2:2020年2月至2021年9月)和一个前瞻组(组3:2021年10月至2022年2月)的新诊断多发性骨髓瘤患者;组1用脊柱MRI开发评分,组2用全身MRI开发评分,组3用全身MRI评分与ISS、R-ISS分期比较。
诊断标准与关键数值
- 总分由骨髓背景模式、局灶性骨病灶数目、髓外或椎旁病灶三项特征相加构成,范围0-9分;三项特征观察者间一致性κ范围0.69-0.80。
临床应用与阅片要点
- 组3全身MRI总分随ISS分期增高而增加:ISS 1、2、3期平均分分别为2.2、4.2、5.8(P=.009)。
- 组3全身MRI总分随R-ISS分期增高而增加:R-ISS 1、2、3期平均分分别为2.1、3.8、5.9(P=.005)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background In patients with multiple myeloma (MM), the serum marker β2-microglobulin does not always accurately reflect tumor load. In contrast, whole-body (WB) MRI has shown high sensitivity for detecting bone lesions. Purpose To develop and validate a semiquantitative WB MRI scoring system for newly diagnosed MM and to compare it with the International Staging System (ISS) and Revised ISS (R-ISS). Materials and Methods This study included two retrospective groups (group 1, July 2015 to September 2021; group 2, February 2020 to September 2021) and one prospective group (group 3, October 2021 to February 2022) of patients with newly diagnosed MM. A new scoring system for MM was developed using spine MRI scans in group 1 and WB MRI scans in group 2 that integrated three features: (a) background marrow pattern, (b) number of focal bone lesions, and (c) presence of extramedullary or paramedullary lesions. The summed total score ranged from zero to nine. The interobserver agreement for each feature was assessed using Fleiss or Cohen weighted κ. WB MRI total scores in group 3 were compared across ISS and R-ISS stages using two-way analysis of variance. Results Groups 1, 2, and 3 included 103 patients (mean age, 62.1 years ± 9.1 [SD]; 60 men), 36 patients (mean age 65.4 years ± 11.3 [SD]; 19 women), and 39 participants (mean age, 62.0 years ± 11.7 [SD]; 20 men), respectively. The interobserver agreements for the three features composing the scoring system were substantial (κ range, 0.69-0.80). WB MRI total score increased with increasing ISS stage (mean score for ISS 1, 2, and 3 was 2.2, 4.2, and 5.8, respectively; P = .009) and R-ISS stage (mean score for R-ISS 1, 2, and 3 was 2.1, 3.8, and 5.9, respectively; P = .005). Conclusion The developed WB MRI scoring system for MM demonstrated substantial observer agreement and corresponded well with ISS and R-ISS stages. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Dragan and Messiou in this issue.
引用
- Kim DK, Jung JY, Kim H, et al. Development of a Semiquantitative Whole-Body MRI Scoring System for Multiple Myeloma. Radiology. 2023. PMID: 37668524. doi:10.1148/radiol.230667
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。